ST. PAUL, Minn.–(BUSINESS WIRE)–Innovia Medical is expanding its global presence by selling InstruSafe Instrument Protection…
Onuu, backed by leading Hispanic VCs, develops first-of-its-kind, all-in-one banking and insurance solution and app…
Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive…
Long-term efficacy data from the pivotal SUNFISH study confirm increases in motor function are sustained…
Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of…
All-in-one ESG management solution enables organizations to comprehensively manage and report on their ESG and…
Sheridan, Wyoming–(Newsfile Corp. – March 16, 2022) – Simplex is excited to partner with Oduwa…
Research reveals 89% of organizations say ransomware attacks in Kubernetes environments are a risk, yet…
DXC to transform PreZero’s IT estate with cloud, workplace and security solutions to support the…
Accenture launches dedicated Metaverse Continuum business group as physical and virtual realities converge to reshape…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (“FF” or the “Company”) (NASDAQ: FFIE), a California-based…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV) today announced the launch of OCE+, the first of…
Submission based on real-world safety and efficacy data from Israel Data showed rates of confirmed…
– Topline data for pivotal Phase 3 trial evaluating brilaroxazine for the treatment of schizophrenia…
– Phase 1/2 trial of INZ-701 in adult patients with ENPP1 Deficiency underway – – Expect to…
Toronto, Ontario–(Newsfile Corp. – March 15, 2022) – Xigem Technologies Corporation (CSE: XIGM) (FSE:2C1) (“Xigem”…
The Slate solar and storage project is now serving Bay Area Rapid Transit, Central Coast…
NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana” or…